
Thiruvananthapuram, Nov 12, 2026: KIMSHEALTH has officially inaugurated its state-of-the-art KIMSHEALTH Genomics Laboratory, bringing cutting-edge genetic science and advanced diagnostic capabilities under one roof. This landmark facility marks a major leap in genetic healthcare, strengthening the scope for early disease detection, accurate diagnosis and more individualised treatment. Minister for Industries and Commerce P. K. Kunhalikutty inaugurated the Genomics Laboratory. KIMSHEALTH Group Chairman and Managing Director Dr. M. I. Sahadulla presided over the function. Vishal Maheshwari Cluster CEO, India 3, Aster DM Quality Care, delivered the Keynote Address. Genomics involves studying an individual's genetic makeup to assess disease risks, enable early diagnosis and guide appropriate treatment.
In his Presidential address, Dr. M. I. Sahadulla said, “Genomics has the potential to transform healthcare through early and accurate diagnosis and more personalised treatment. The government and private sector must work together to make its benefits accessible to all. KIMSHEALTH remains committed to supporting the government’s healthcare initiatives and we will ensure that the facilities of our Genomics Laboratory are accessible and affordable to the people.”
He further added that over 100 patients are awaiting bone marrow transplant in the region and that KIMSHEALTH is willing to offer the procedure at rates on par with those in the public sector.
"Kerala has established itself as one of the leading healthcare destinations in the country. I congratulate KIMSHEALTH on this important initiative of setting up the KIMSHEALTH Genomics Laboratory, which will further strengthen the State’s healthcare sector. The benefits of precision medicine must reach all sections of society. The Kerala Government is keen to work in partnership with the private sector to make advanced medical facilities and treatments accessible and affordable to everyone. Ensuring that quality healthcare is within the reach of all should remain our collective priority,” said P K Kunhalikutty, Minister for Industries and Commerce.
In his Keynote address, Vishal Maheshwari said, " “Providing the right treatment at the right time is crucial to achieving the best possible health outcomes. Early diagnosis and timely medical intervention can make a significant difference in saving lives and improving the quality of life.”
The laboratory has a multidisciplinary team of clinical geneticists, genetic counselors and experienced research scientists. KIMSHEALTH also plans to expand access to genetic testing through collaborations with public and private healthcare institutions and medical research centres. Beyond targeted oncology and cancer care, advanced genomics plays a pivotal role across multiple medical specialties, including reproductive and fertility medicine, pediatrics, cardiology, neurology, nephrology and other adult rare diseases. The laboratory has so far processed and evaluated over 3,000 genetic samples, since inception.
E M Najeeb, Co- founder KIMSHEALTH, welcomed the gathering. Dr. Roshan Daniel, Associate Consultant, Clinical Genetics and Precision Medicine, presented an overview of the Genomics Laboratory. Dr. B Rajan, Director, Clinical Services, KIMSHEALTH, proposed the vote of thanks.

